The Dr. Mehta trial in Albany has stopped, and the Hubbard Foundation has decided to not pursue further research. Dr. Dake's trial has not yet begun due to waiting for a neurologist partner to come onboard, and now Dr. Goodin has shown an interest, so we'll have to see if something comes of that.
Here's the clinical gov site for some of the other studies underway:
http://clinicaltrials.gov/ct2/results?term=ccsviI wasn't aware that Dr Hunter of University of Stirling had a study planned. "Functional Changes Following Percutaneous Venoplasty in Multiple Sclerosis Patients"
Quote:
Accordingly the investigators propose to use a repeated measures design on an experimental (receiving venoplasty) and control (not receiving venoplasty) MS groups (6 patients in each group) to determine the effect of the treatment on muscular function, mobility and fatigue. This would be combined with independent blinded neurological assessment of the two groups of patients.
Really small sample but the independent blinded neurological assessment sounds good, as done having a treatment group and a control group.